Chau-Ting Yeh
Overview
Explore the profile of Chau-Ting Yeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
281
Citations
3436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsiao Y, Chang C, Yeh C, Ke P
Pathogens
. 2025 Jan;
13(12.
PMID: 39770398
Chronic HCV infection is a risk factor for end-stage liver disease, leading to a major burden on public health. Mitophagy is a specific form of selective autophagy that eliminates mitochondria...
2.
Lin Y, Chen C, Chi H, Wu M, Lai M, Yeh C
Transl Oncol
. 2024 Dec;
52():102250.
PMID: 39708716
Liver cancer, encompassing hepatocellular carcinoma (HCC) and hepatoblastoma, the latter of which primarily occurs in early childhood, is the most common malignant tumor arising from liver and is responsible for...
3.
Lin Y, Chi H, Wu M, Liao C, Chen C, Huang P, et al.
Int J Biol Sci
. 2024 Dec;
20(15):6281-6296.
PMID: 39664573
Pseudogene-derived long non-coding RNAs (lncRNAs) have become crucial regulators in cancer progression. Extensive research highlights the pivotal role of signal transducer and activator of transcription 3 (STAT3) in promoting hepatocellular...
4.
Ke P, Yeh C
Pathogens
. 2024 Nov;
13(11).
PMID: 39599533
Many types of RNA viruses, including the hepatitis C virus (HCV), activate autophagy in infected cells to promote viral growth and counteract the host defense response. Autophagy acts as a...
5.
Chu Y, Hsu C, Ho P, Chiou C, Lin C, Liang K, et al.
J Gastroenterol Hepatol
. 2024 Nov;
40(1):265-273.
PMID: 39500510
Background And Aim: Hepatitis B virus (HBV) reactivation could develop after withdrawal following a finite course of nucleoside analog (NA) therapy, leading to virological and clinical relapses. The genetic heterogeneity...
6.
Poddar M, Chu Y, Yeh C, Liu C
Lab Chip
. 2024 Oct;
24(23):5264.
PMID: 39480687
Correction for 'Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms' by Madhu Shree Poddar , , 2024, , 3668-3678, https://doi.org/10.1039/D4LC00238E.
7.
Lee H, Chuang H, Lin K, Yeh C, Wang Y, Chi H, et al.
Am J Cancer Res
. 2024 Oct;
14(9):4320-4336.
PMID: 39417186
Glioblastoma (GBM) is the most malignant brain tumor frequently characterized by a hypoxic microenvironment. In this investigation, we unveiled unprecedented role of Ribonuclease 4 (RNASE4) in GBM pathogenesis through integrative...
8.
Chu Y, Chen M, Yeh C, Lai M
J Biomed Sci
. 2024 Oct;
31(1):97.
PMID: 39369194
Recent advances in studies exploring the roles of extracellular vesicles (EVs) in viral transmission and replication have illuminated hepatotropic viruses, such as hepatitis A (HAV), hepatitis B (HBV), hepatitis C...
9.
Poddar M, Chu Y, Pendharkar G, Liu C, Yeh C
Lab Chip
. 2024 Oct;
24(21):5043-5054.
PMID: 39356081
Liver cancer is a significant global contributor to cancer-related mortality. Despite available targeted therapies, resistance to tyrosine kinase inhibitors (TKIs) like sorafenib and lenvatinib poses a formidable challenge. The tumor...
10.
Lin Y, Yeh C, Chen C, Lin K
Biomed J
. 2024 Sep;
:100790.
PMID: 39305992
With the advancement of high-throughput technologies, the pivotal role of non-coding RNA (ncRNA) as a master regulator of various biological functions has become increasingly apparent. Historically considered non-functional and labeled...